B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 2.14 EUR 7% Market Closed
Market Cap: 49.9m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Bioretec Oy
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioretec Oy
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioretec Oy
OMXH:BRETEC
Interest Income Expense
-€753.8k
CAGR 3-Years
-31%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Interest Income Expense
-€759k
CAGR 3-Years
-53%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
M
Modulight Oyj
OMXH:MODU
Interest Income Expense
€272k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Interest Income Expense
-€495k
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Interest Income Expense
-€121.7k
CAGR 3-Years
56%
CAGR 5-Years
22%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Interest Income Expense
€371k
CAGR 3-Years
27%
CAGR 5-Years
55%
CAGR 10-Years
-1%
No Stocks Found

Bioretec Oy
Glance View

Market Cap
49.9m EUR
Industry
Health Care

Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.

BRETEC Intrinsic Value
3.33 EUR
Undervaluation 36%
Intrinsic Value
Price
B

See Also

What is Bioretec Oy's Interest Income Expense?
Interest Income Expense
-753.8k EUR

Based on the financial report for Dec 31, 2023, Bioretec Oy's Interest Income Expense amounts to -753.8k EUR.

What is Bioretec Oy's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-11%

Over the last year, the Interest Income Expense growth was -510%. The average annual Interest Income Expense growth rates for Bioretec Oy have been -31% over the past three years , -11% over the past five years .

Back to Top